291 related articles for article (PubMed ID: 38794764)
1. Cholesterol-Lowering Bioactive Foods and Nutraceuticals in Pediatrics: Clinical Evidence of Efficacy and Safety.
Fogacci F; ALGhasab NS; Di Micoli V; Giovannini M; Cicero AFG
Nutrients; 2024 May; 16(10):. PubMed ID: 38794764
[TBL] [Abstract][Full Text] [Related]
2. Diet and Cardiovascular Disease Risk Among Individuals with Familial Hypercholesterolemia: Systematic Review and Meta-Analysis.
Barkas F; Nomikos T; Liberopoulos E; Panagiotakos D
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32823643
[TBL] [Abstract][Full Text] [Related]
3. Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
Cicero AFG; Fogacci F; Stoian AP; Vrablik M; Al Rasadi K; Banach M; Toth PP; Rizzo M
Curr Atheroscler Rep; 2021 Aug; 23(10):57. PubMed ID: 34345932
[TBL] [Abstract][Full Text] [Related]
4. Nutraceuticals for the treatment of hypercholesterolemia.
Mannarino MR; Ministrini S; Pirro M
Eur J Intern Med; 2014 Sep; 25(7):592-9. PubMed ID: 24997485
[TBL] [Abstract][Full Text] [Related]
5. Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.
Cicero AF; Derosa G; Pisciotta L; Barbagallo C;
J Med Food; 2015 Nov; 18(11):1270-3. PubMed ID: 26274827
[TBL] [Abstract][Full Text] [Related]
6. A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence.
Barrios V; Escobar C; Cicero AF; Burke D; Fasching P; Banach M; Bruckert E
Atheroscler Suppl; 2017 Feb; 24():1-15. PubMed ID: 27998714
[TBL] [Abstract][Full Text] [Related]
7. Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence.
Patch CS; Tapsell LC; Williams PG; Gordon M
Vasc Health Risk Manag; 2006; 2(2):157-62. PubMed ID: 17319460
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk.
Bianconi V; Mannarino MR; Sahebkar A; Cosentino T; Pirro M
Curr Cardiol Rep; 2018 May; 20(7):53. PubMed ID: 29802549
[TBL] [Abstract][Full Text] [Related]
9. Plant Sterols and Plant Stanols in Cholesterol Management and Cardiovascular Prevention.
Barkas F; Bathrellou E; Nomikos T; Panagiotakos D; Liberopoulos E; Kontogianni MD
Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447172
[TBL] [Abstract][Full Text] [Related]
10. Joint position statement on "Nutraceuticals for the treatment of hypercholesterolemia" of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA).
Pirro M; Vetrani C; Bianchi C; Mannarino MR; Bernini F; Rivellese AA
Nutr Metab Cardiovasc Dis; 2017 Jan; 27(1):2-17. PubMed ID: 27956024
[TBL] [Abstract][Full Text] [Related]
11. Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease.
Gylling H; Plat J; Turley S; Ginsberg HN; Ellegård L; Jessup W; Jones PJ; Lütjohann D; Maerz W; Masana L; Silbernagel G; Staels B; Borén J; Catapano AL; De Backer G; Deanfield J; Descamps OS; Kovanen PT; Riccardi G; Tokgözoglu L; Chapman MJ;
Atherosclerosis; 2014 Feb; 232(2):346-60. PubMed ID: 24468148
[TBL] [Abstract][Full Text] [Related]
12. Powdered red yeast rice and plant stanols and sterols to lower cholesterol.
Feuerstein JS; Bjerke WS
J Diet Suppl; 2012 Jun; 9(2):110-5. PubMed ID: 22531006
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of Nutraceuticals with Lipid Lowering Properties.
Poli A; Visioli F
High Blood Press Cardiovasc Prev; 2019 Apr; 26(2):113-118. PubMed ID: 30877602
[TBL] [Abstract][Full Text] [Related]
14. LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies.
Ras RT; Geleijnse JM; Trautwein EA
Br J Nutr; 2014 Jul; 112(2):214-9. PubMed ID: 24780090
[TBL] [Abstract][Full Text] [Related]
15. Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data.
Cicero AF; Colletti A
Phytomedicine; 2016 Oct; 23(11):1113-8. PubMed ID: 26621556
[TBL] [Abstract][Full Text] [Related]
16. Current Drugs and Nutraceuticals for the Treatment of Patients with Dyslipidemias.
Scognamiglio M; Costa D; Sorriento A; Napoli C
Curr Pharm Des; 2019; 25(1):85-95. PubMed ID: 30706799
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol-lowering nutraceuticals and functional foods.
Chen ZY; Jiao R; Ma KY
J Agric Food Chem; 2008 Oct; 56(19):8761-73. PubMed ID: 18778072
[TBL] [Abstract][Full Text] [Related]
18. Improvement of cholesterol levels and reduction of cardiovascular risk via the consumption of phytosterols.
Ortega RM; Palencia A; López-Sobaler AM
Br J Nutr; 2006 Aug; 96 Suppl 1():S89-93. PubMed ID: 16923260
[TBL] [Abstract][Full Text] [Related]
19. Plant sterols and stanols as cholesterol-lowering ingredients in functional foods.
Kamal-Eldin A; Moazzami A
Recent Pat Food Nutr Agric; 2009 Jan; 1(1):1-14. PubMed ID: 20653521
[TBL] [Abstract][Full Text] [Related]
20. Functional foods and nutraceuticals in the treatment of hypercholesterolemia: Statement of the Spanish Society of Arteriosclerosis 2023.
Pérez-Martínez P; Ros E; Pedro-Botet J; Civeira F; Pascual V; Garcés C; Solá R; Pérez-Jiménez F; Mostaza JM
Clin Investig Arterioscler; 2023; 35(5):248-261. PubMed ID: 36932013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
